Concepedia

Lukas Fiebig

LF

10

Publications

382

Citations

10

H-Index

2011

Active since

Affiliations

University of Cologne(Current)

Bayer (Germany)

Lukas Fiebig is an author at University of Cologne specializing in chemistry, engineering, and natural sciences.

ORCID

Top concepts

Publications per year

2011–2023

10

Publications

10

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Kohei Shigeta, Aya Matsui, Hiroto Kikuchi et al. · Journal for ImmunoTherapy of Cancer · 2020 · 143 citations · Full text

Cobalt Catalysis in the Gas Phase: Experimental Characterization of Cobalt(I) Complexes as Intermediates in Regioselective Diels–Alder Reactions

Lukas Fiebig, Julian Kuttner, Gerhard Hilt et al. · The Journal of Organic Chemistry · 2013 · 60 citations

, , +13

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

Maria Kissel, Sandra Berndt, Lukas Fiebig et al. · Oncotarget · 2017 · 58 citations · Full text

Rhodium‐Catalyzed Enantioselective Intramolecular [4+2] Cycloaddition using a Chiral Phosphine‐Phosphite Ligand: Importance of Microwave‐Assisted Catalyst Conditioning

Anna Falk, Lukas Fiebig, Jörg‐Martin Neudörfl et al. · Advanced Synthesis & Catalysis · 2011 · 28 citations

, , +16

Fragmentation reactions of thiourea- and urea-compounds examined by tandem MS-, energy-resolved CID experiments, and theory

Francesco Falvo, Lukas Fiebig, Frank Dreiocker et al. · International Journal of Mass Spectrometry · 2012 · 20 citations

, , +8

Rows per page

1–5 of 10